A Microcap “hat trick”, one IPO, one uplisting, and one direct listing completed within 90 days. Another first for the industry led by Lucosky Brookman. The transactions included ROC’s Nasdaq IPO, which ended a 78-day Nasdaq microcap IPO drought and became the first Nasdaq microcap IPO of 2026, Bimergen Energy’s NYSE American uplisting alongside a $13.6 million underwritten offering, and Lakewood-Amedex Biotherapeutics’ direct listing transaction. Three different paths to the public markets, each requiring a distinct strategy and proactive execution.
The Lucosky Brookman team continues to grow. We recently welcomed three new attorneys to the firm, further strengthening our Capital Markets and Insurance Coverage & Defense practices.
We are especially excited to welcome Andrea Cataneo as Partner in our Capital Markets group. Andrea has built an exceptional reputation across the emerging growth and microcap ecosystem, bringing decades of experience advising companies, investment banks, and market participants. Her entrepreneurial mindset, industry relationships, and deep understanding of the capital markets landscape make her a significant addition to the Lucosky Brookman team.
Bring Your Child to Work Day has become one of our favorite traditions at Lucosky Brookman, giving the next generation a firsthand look at the work we do every day. From exploring the office to learning more about the legal and financial industries, the day is always filled with curiosity, energy, and plenty of great questions. It is a reminder of the importance of investing in future leaders and encouraging young minds to think bigger about what is possible.
Our Q1 2026 Microcap Brief highlights a capital markets environment that remains active, but significantly more selective. While companies continue pursuing IPOs, uplists, cross-listings, and direct listings, exchanges are applying greater scrutiny across transaction structure, investor composition, governance, and overall deal quality.
The report examines the continued slowdown in traditional IPO activity, the rise in direct listings, the evolution of uplist and cross-list strategies, and the broader impact of Nasdaq’s expanded discretionary review authority under IM-5101-3. The theme throughout the quarter showed that meeting minimum listing standards alone is no longer enough in today’s market environment.
Lucosky Brookman LLP has pioneered a hands-on, end-to-end approach to guiding entrepreneurial, emerging growth and public companies through complex legal and business challenges. Built on the belief that clients need more than legal advice, the firm leads strategy, coordinates stakeholders, and executes across the full corporate lifecycle, serving as the central point of command for transactions, litigation, and regulatory matters. Headquartered in the New York metropolitan area with attorneys across the country, Lucosky Brookman represents domestic and international clients across capital markets transactions, mergers and acquisitions, financing matters, complex commercial and securities litigation, white collar and regulatory matters, and insurance coverage and defense, with a relationship-driven, results-focused approach centered on accountability, execution, and long-term partnership.
Explore the full range of Lucosky Brookman's practice areas.
.png?utm_source=hs_email&utm_medium=email&_hsenc=p2ANqtz-8FZOFLrQ6aA9zQYdIgXqVZ8lMQ31XDhbbNKMbP-1OGYKD-ONqk8attboIC-8oGTQjNGiLc)
_Page_01.png?upscale=true&width=1120&upscale=true&name=Q1%20Mircocap%20Brief%20v2%20(3)_Page_01.png)
.png?upscale=true&width=518&upscale=true&name=White%20Logo%20-%20high-res%20(1).png)
